Gadodiamide
Modify Date: 2024-01-08 00:42:15
Gadodiamide structure
|
Common Name | Gadodiamide | ||
|---|---|---|---|---|
| CAS Number | 122795-43-1 | Molecular Weight | 591.67200 | |
| Density | N/A | Boiling Point | 769.1ºC at 760mmHg | |
| Molecular Formula | C16H28GdN5O9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 419ºC | |
Use of GadodiamideGadodiamide is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Target: OthersGadodiamide(Omniscan) is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Gadodiamide is a contrast medium for cranial and spinal magnetic resonance imaging (MRI) and for general MRI of the body after intravenous administration. The product provides contrast enhancement and facilitates visualisation of abnormal structures or lesions in various parts of the body including the central nervous system (CNS). A recent review takes the question of toxicity caused by loss of gadolinium from the complex. "The challenge for nephrologists includes (a) evidence of transmetallation, such as gadolinium deposits in bone, increased urinary zinc excretion, iron-transferrin dissociation or 'spurious hypocalcemia' in exposed people" [1]. |
| Name | gadodiamide hydrate |
|---|---|
| Synonym | More Synonyms |
| Description | Gadodiamide is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Target: OthersGadodiamide(Omniscan) is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Gadodiamide is a contrast medium for cranial and spinal magnetic resonance imaging (MRI) and for general MRI of the body after intravenous administration. The product provides contrast enhancement and facilitates visualisation of abnormal structures or lesions in various parts of the body including the central nervous system (CNS). A recent review takes the question of toxicity caused by loss of gadolinium from the complex. "The challenge for nephrologists includes (a) evidence of transmetallation, such as gadolinium deposits in bone, increased urinary zinc excretion, iron-transferrin dissociation or 'spurious hypocalcemia' in exposed people" [1]. |
|---|---|
| Related Catalog | |
| References |
| Boiling Point | 769.1ºC at 760mmHg |
|---|---|
| Molecular Formula | C16H28GdN5O9 |
| Molecular Weight | 591.67200 |
| Flash Point | 419ºC |
| Exact Mass | 592.11300 |
| PSA | 156.05000 |
| Storage condition | -20℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Gadodiamide hydrate |
| Omniscan |
| 2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate,gadolinium(3+),hydrate |